Tags

ALS drug

Ractigen Therapeutics completes trial enrolment for ALS drug

Ractigen Therapeutics completes trial enrolment for ALS drug

August 07, 2026 | 15:26
Ractigen Therapeutics completed patient enrolment and initial dosing across all cohort groups in its Phase II clinical trial evaluating RAG-17 for ALS treatment.

Latest News

Vietnam and Russia boost transport ties at international summit

Vietnam and Russia boost transport ties at international summit

AsiaWorld Expo offers 12 percent dining discount for visitors

AsiaWorld Expo offers 12 percent dining discount for visitors

Japan's MISUMI invests $31 million to expand manufacturing capacity in Vietnam and beyond

Japan's MISUMI invests $31 million to expand manufacturing capacity in Vietnam and beyond

Solidion Technology completes private placement to eliminate debt overhang

Solidion Technology completes private placement to eliminate debt overhang

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society Swing for the Kids CSR
World News
virs-publications-vir
timeout-vn
ptbv2020